Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
155 DKK | -0.10% | -2.05% | -12.68% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
Sales 2024 * | 5.18B 748M | Sales 2025 * | 4.99B 720M | Capitalization | 12.08B 1.75B |
---|---|---|---|---|---|
Net income 2024 * | 646M 93.34M | Net income 2025 * | 855M 124M | EV / Sales 2024 * | 2.22 x |
Net cash position 2024 * | 569M 82.27M | Net cash position 2025 * | 861M 124M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
14.2
x | Employees | 1,379 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.7% |
Latest transcript on Bavarian Nordic A/S
1 day | -0.10% | ||
1 week | -2.05% | ||
Current month | -0.80% | ||
1 month | -3.46% | ||
3 months | -14.25% | ||
6 months | +0.75% | ||
Current year | -12.68% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Chaplin
CEO | Chief Executive Officer | 57 | 98-12-31 |
Henrik Juuel
DFI | Director of Finance/CFO | 59 | 18-10-31 |
Russell Thirsk
COO | Chief Operating Officer | 56 | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Pedersen
BRD | Director/Board Member | 73 | 10-04-26 |
Director/Board Member | 57 | 22-12-31 | |
Frank Verwiel
BRD | Director/Board Member | 62 | 16-04-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 735 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 155 | -0.10% | 193,997 |
24-03-26 | 155.1 | +0.91% | 379,123 |
24-03-25 | 153.7 | -1.98% | 337,427 |
24-03-22 | 156.8 | -0.88% | 569,062 |
24-03-21 | 158.2 | +1.41% | 377,171 |
Delayed Quote Nasdaq Copenhagen, March 27, 2024 at 11:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.68% | 1.75B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |